Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2015,NCI,1K22CA181550-01,,Targeting defective DNA repair for the prevention of BRCA1-associated cancers,"ALLI, ELIZABETH",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$162,000"
Ovarian Cancer,2015,NCI,3R01CA149429-05S1,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$25,000"
Ovarian Cancer,2015,NCI,5K08CA151892-05,,Targeting SRC Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF PENNSYLVANIA,PA,"$30,798"
Ovarian Cancer,2015,NIAID,5R01AI033993-21,,Processed Antigen Characterization by Mass Spectrometry,"HUNT, DONALD",UNIVERSITY OF VIRGINIA,VA,"$633,862"
Ovarian Cancer,2015,NCI,5R01CA158415-04,,Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$356,850"
Ovarian Cancer,2015,NCI,5R01CA079716-16,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$326,412"
Ovarian Cancer,2015,NCI,5R21CA182715-02,,Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty,"FRIDLEY, BROOKE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$212,938"
Ovarian Cancer,2015,NCI,5R01CA097061-12,,Chemical genetic profiling of engineered tumor cells,"STOCKWELL, BRENT",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$350,176"
Ovarian Cancer,2015,NCI,5R03CA181907-02,,Diagnostic Utility of Culdocentesis in Patients with a Suspicious Adnexal Mass,"BRARD, LAURENT",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$73,750"
Ovarian Cancer,2015,NCI,5R01CA172743-03,,Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients,"SUTPHEN, REBECCA",UNIVERSITY OF SOUTH FLORIDA,FL,"$216,572"
Ovarian Cancer,2015,NCI,5R00CA168987-03,,Discovering genomic rearrangements under selection in serious ovarian cancer,"SALZMAN, JULIA",STANFORD UNIVERSITY,CA,"$234,786"
Ovarian Cancer,2015,NCI,5R03CA175462-02,,Trial Participation Decision Making in Ovarian Cancer Patients and Their Families,"RADECKI BREITKOPF, CARMEN",MAYO CLINIC ROCHESTER,MN,"$79,500"
Ovarian Cancer,2015,NCI,5R01CA174470-24,,Stimulation of Tumorigenesis by NKG2D,"SPIES, THOMAS",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$646,415"
Ovarian Cancer,2015,NCI,5P30CA006516-50,6051,Gynecologic Cancers,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$93,399"
Ovarian Cancer,2015,NCI,5P30CA006516-50,6064,Cancer Epidemiology,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$82,467"
Ovarian Cancer,2015,NCI,5R01CA135650-06,,Predictive Cancer Diagnostics and Therapy Response,"MOORE, ANNA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$552,368"
Ovarian Cancer,2015,NCI,5R01CA163462-04,,MUC1 Roles in ovarian cancer pathogenesis and immune therapy,"VLAD, ANDA",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$287,764"
Ovarian Cancer,2015,NCI,5R01CA047135-25,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$644,409"
Ovarian Cancer,2015,NCI,5R01CA174643-08,,The role of ERRalpha/PGC-1 in disease pathogenesis,"MCDONNELL, DONALD",DUKE UNIVERSITY,NC,"$314,209"
Ovarian Cancer,2015,NCI,2P01CA087969-16,8092,Core A: Biospecimen and High-Dimensional Data Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$680,717"
Ovarian Cancer,2015,NCI,2P01CA087969-16,8096,Project 3: Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$240,125"
Ovarian Cancer,2015,NCI,2P01CA087969-16,8097,Project 4: Statistical Innovations,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$150,307"
Ovarian Cancer,2015,NIGMS,1SC1CA199810-01,,Novel Nanotechnology Platform for Breast Cancer Treatment,"AKALA, EMMANUEL",HOWARD UNIVERSITY,DC,"$377,500"
Ovarian Cancer,2015,NCI,1R01CA190423-01,,Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$403,288"
Ovarian Cancer,2015,NCI,1R01CA190498-01,,gp130 as a novel therapeutic target in ovarian cancer,"NEAMATI, NOURI",UNIVERSITY OF MICHIGAN,MI,"$376,907"
Ovarian Cancer,2015,NCI,1R01CA190237-01,,Targeting BRCA Deficient Cells for Killing,"POMERANTZ, RICHARD",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$356,850"
Ovarian Cancer,2015,NIBIB,1R01EB019458-01,,Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling,"CONOLLY, STEVEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$512,584"
Ovarian Cancer,2015,NCI,1R01CA186700-01A1,,Study of biomarkers in ovarian cancer: modulation by activity & diet intervention,"THOMSON, CYNTHIA",UNIVERSITY OF ARIZONA,AZ,"$647,789"
Ovarian Cancer,2015,NCI,2P30CA015704-40,5446,Research Program: Women's Cancer,"PORTER, PEGGY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$71,271"
Ovarian Cancer,2015,NCI,5UM1CA173642-03,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,539,856"
Ovarian Cancer,2015,NCI,5R01CA182832-02,,An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer,"MATEI, DANIELA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Ovarian Cancer,2015,NCI,1R21CA190930-01,,Subharmonic Contrast Ultrasound for Improved Characterization of Adnexal Masses,"FORSBERG, FLEMMING",THOMAS JEFFERSON UNIVERSITY,PA,"$203,580"
Ovarian Cancer,2015,NCI,5R01CA166711-03,,Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport,"GANGJEE, ALEEM",DUQUESNE UNIVERSITY,PA,"$558,208"
Ovarian Cancer,2015,NCI,1R21CA185808-01A1,,Genetic Testing For Men From Hereditary Cancer Families,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$202,928"
Ovarian Cancer,2015,NCI,1R21CA191690-01,,Identifying BRCA1 protein variants that provide resistance to therapy,"JOHNSON, NEIL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$194,119"
Ovarian Cancer,2015,NCI,1R03CA184394-01A1,,Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer,"LU, XIULING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$79,000"
Ovarian Cancer,2015,NCI,5K99CA175292-02,,Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms,"RIZVI, IMRAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$174,871"
Ovarian Cancer,2015,NCI,5R01CA163345-04,,Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics,"BUCKANOVICH, RONALD",UNIVERSITY OF MICHIGAN,MI,"$322,663"
Ovarian Cancer,2015,NCI,1R01CA175318-01A1,,A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer,"HATEFI, ARASH","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$354,563"
Ovarian Cancer,2015,NCI,5R01CA155025-05,,The role of a novel BRCA1 associated complex in DNA damage response and tumor sup,"WANG, BIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2015,NIGMS,1R01GM113253-01A1,,Role of the checkpoint clamp in double-strand break repair,"KAI, MIHOKO",JOHNS HOPKINS UNIVERSITY,MD,"$311,850"
Ovarian Cancer,2015,NCI,5F31CA183531-02,,Targeting Gain-of-Function p53 Missense Mutants,"SHAVER, TIMOTHY",VANDERBILT UNIVERSITY,TN,"$27,772"
Ovarian Cancer,2015,NCI,5R01CA149669-06,,CD73 and tumor immunity,"ZHANG, BIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$311,894"
Ovarian Cancer,2015,NCI,5R01CA169200-03,,The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$372,052"
Ovarian Cancer,2015,NCI,1R01CA184088-01A1,,Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy,"KABANOV, ALEXANDER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$344,549"
Ovarian Cancer,2015,NCI,5F32CA177094-02,,Peptide-mediated delivery of siRNA for treatment of ovarian cancer,"KWON, ESTER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$57,962"
Ovarian Cancer,2015,NCI,1K22CA181611-01A1,,Online monitoring and image-guided treatment of chemoresistant micrometastases,"SPRING, BRYAN",NORTHEASTERN UNIVERSITY,MA,"$186,276"
Ovarian Cancer,2015,NCI,5R00CA139006-05,,Development of Targeted Therapy for ERK Pathway in Breast Cancer,"BARTHOLOMEUSZ, CHANDRA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$249,000"
Ovarian Cancer,2015,NCI,1R21CA187309-01A1,,Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells,"BARUA, ANIMESH",RUSH UNIVERSITY MEDICAL CENTER,IL,"$214,128"
Ovarian Cancer,2015,NCI,5R01CA159042-05,,Personalizing Nanoparticle Therapy,"KUNDRA, VIKAS",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$324,113"
Ovarian Cancer,2015,NCI,5R01CA148826-05,,Characterizing Notch3 Signaling in Ovarian Cancer,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2015,NCI,5R01CA152470-05,,Memory T Cells in the Tumor Microenvironment,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$393,042"
Ovarian Cancer,2015,NCI,5R01CA169604-03,,Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$392,850"
Ovarian Cancer,2015,NCI,5K22CA175262-04,,Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection,"SCHLACHER, KATHARINA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$200,340"
Ovarian Cancer,2015,NCI,5R21CA178255-02,,Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance.,"WU, TZYY-CHOOU",JOHNS HOPKINS UNIVERSITY,MD,"$176,175"
Ovarian Cancer,2015,NCI,5R01CA168758-03,,Epidemiologic factors and survival by molecular subtypes of ovarian cancer,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$621,252"
Ovarian Cancer,2015,NCI,5R01CA158119-04,,Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$428,829"
Ovarian Cancer,2015,NCI,5R01CA043054-28,,Nuclear Function of Abl in DNA Damage Response,"WANG, JEAN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$387,500"
Ovarian Cancer,2015,NCI,5F31CA183547-02,,Epigenetics and Risk Factors for Breast and Ovarian Cancer in High Risk Women,"FERRIS, JENNIFER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$41,643"
Ovarian Cancer,2015,NCI,5R01CA160687-05,,Targeted Development of Platinum Drugs,"SIDDIK, ZAHID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2015,NCI,5F30CA167895-04,,Molecular analysis of the function of BRCA1-TONSL complexes,"HILL, SARAH",HARVARD MEDICAL SCHOOL,MA,"$45,762"
Ovarian Cancer,2015,NCI,1R41CA192689-01,,Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells,"SZOKA, FRANCIS","ZONEONE PHARMA, INC.",CA,"$298,920"
Ovarian Cancer,2015,NCI,5R21CA185730-02,,Blood-based Angiome Profiling  to Direct Bevacizumab Therapy in Ovarian Cancer,"SECORD, ANGELES",DUKE UNIVERSITY,NC,"$207,061"
Ovarian Cancer,2015,NCI,1R43CA186562-01A1,,Modified MIS Production & Process Development for Preclinical & Clinical Studies,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$225,000"
Ovarian Cancer,2015,NIGMS,5F32GM110978-02,,Deciphering the epistatic relationships of RAD51 Paralogs in mammary epithelium,"PRAKASH, ROHIT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$59,966"
Ovarian Cancer,2015,NCI,5R01CA172272-03,,The BARD1 tumor suppressor and breast cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Ovarian Cancer,2015,NCI,5R01CA157664-05,,Initiation and evolution of the ovarian cancer microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$379,960"
Ovarian Cancer,2015,NCI,5R01CA158881-05,,Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$523,530"
Ovarian Cancer,2015,NCI,5R01CA181543-02,,Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells,"BRUGGE, JOAN",HARVARD MEDICAL SCHOOL,MA,"$397,851"
Ovarian Cancer,2015,NCI,5R01CA183040-02,,Ovarian cancer gene therapy using HPV pseudovirion,"WU, TZYY-CHOOU",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Ovarian Cancer,2015,NCI,5R01CA160669-04,,Mitochondrial DNA and Ovarian Cancer Risk and Survival,"COOK, LINDA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$505,309"
Ovarian Cancer,2015,NCI,5R01CA154460-05,,CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$345,488"
Ovarian Cancer,2015,NCI,5R01CA174904-03,,Roles of Chromatin Modification in BRCA1 Dependent DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$332,000"
Ovarian Cancer,2015,NIBIB,5R01EB016582-03,,Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer,"NOLTE, DAVID",PURDUE UNIVERSITY,IN,"$317,506"
Ovarian Cancer,2015,NCI,5U10CA180860-02,,Integrated Translational Genoproteomics Center at Washington University,"MUTCH, DAVID",WASHINGTON UNIVERSITY,MO,"$570,826"
Ovarian Cancer,2015,NCI,5R01CA184968-02,,(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$509,161"
Ovarian Cancer,2015,NCI,5R01CA109545-09,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$298,049"
Ovarian Cancer,2015,NCI,5R01CA155305-05,,Multiplexed Detection of Cell Free DNA Biomarkers for Cancer,"WANG, TZA-HUEI",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2015,NCI,5U01CA176058-03,,The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$703,315"
Ovarian Cancer,2015,NIGMS,5R01GM111093-02,,Glycosylation-dependent mechanisms regulating ovarian tumor cell survival,"BELLIS, SUSAN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$279,300"
Ovarian Cancer,2015,NCI,5R01CA184502-02,,(PQD5) Avatar-directed Treatment for Ovarian Cancer,"WEROHA, SARAVUT",MAYO CLINIC ROCHESTER,MN,"$642,667"
Ovarian Cancer,2015,NCI,5R01CA151570-05,,Co-registered photoacoustic and ultrasound  imaging  for non-invasive ovarian can,"ZHU, QUING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$324,140"
Ovarian Cancer,2015,NCI,5R01CA109298-11,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$359,706"
Ovarian Cancer,2015,NCI,5R01CA131407-08,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$326,334"
Ovarian Cancer,2015,NCI,5K99CA184043-02,,Targeting Ovarian Cancer via Cooperative Oncogene Interactions,"HARGREAVES, DIANA",STANFORD UNIVERSITY,CA,"$171,072"
Ovarian Cancer,2015,NCI,5R01CA160998-05,,Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$387,435"
Ovarian Cancer,2015,NIBIB,5R01EB007268-08,,Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity,"YANG, JENNY",GEORGIA STATE UNIVERSITY,GA,"$459,558"
Ovarian Cancer,2015,NICHD,5R01HD073499-03,,Genetic regulation of ovariole development in Drosophila,"EXTAVOUR, CASSANDRA",HARVARD UNIVERSITY,MA,"$309,413"
Ovarian Cancer,2015,NCI,5R01CA175480-03,,Tumor-targeted Polymersomes to image and Treat Ovarian Cancer,"CHENG, ZHILIANG",UNIVERSITY OF PENNSYLVANIA,PA,"$327,765"
Ovarian Cancer,2015,NCI,5R01CA068682-24,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$320,588"
Ovarian Cancer,2015,NCI,5R01CA177909-03,,Platelets promote growth of ovarian cancer,"AFSHAR-KHARGHAN, VAHID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$332,000"
Ovarian Cancer,2015,NCI,5R01CA163377-04,,Role of EZH2 in Epithelial Ovarian Cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$345,488"
Ovarian Cancer,2015,NCI,5R01CA180769-07,,Signaling Connections Controlling Cell Motility and Invasion,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$376,450"
Ovarian Cancer,2015,NIGMS,1R01GM113940-01,,NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers,"YOU, YOUNGJAE",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$279,404"
Ovarian Cancer,2015,NCI,5R01CA176078-02,,Dissecting the role of STAT3 and targeting ovarian cancer,"KARUPPAIYAH, SELVENDIRAN",OHIO STATE UNIVERSITY,OH,"$323,379"
Ovarian Cancer,2015,NCI,5R01CA075334-18,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,773"
Ovarian Cancer,2015,NCI,1U01CA194393-01,,Quantifying and Characterizing the shared genetic contribution to common cancers,"LINDSTROEM, SARA",HARVARD SCHOOL OF PUBLIC HEALTH,MA,"$675,732"
Ovarian Cancer,2015,NCI,5U01CA176270-03,,Profiling cancer neoantigen repertoires and validating immunotherapy targets,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,069,555"
Ovarian Cancer,2015,NCI,5R01CA157481-04,,"Bmi-1, a potential therapeutic target in ovarian cancer","BHATTACHARYA, RESHAM",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$311,480"
Ovarian Cancer,2015,NCI,5F31CA177325-02,,Inflammatory Basis of Depression in Ovarian Cancer,"SCHREPF, ANDREW",UNIVERSITY OF IOWA,IA,"$8,598"
Ovarian Cancer,2015,NCI,1K99CA194318-01,,Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer,"BITLER, BENJAMIN",WISTAR INSTITUTE,PA,"$115,014"
Ovarian Cancer,2015,NCI,1K99CA194309-01,,Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer,"AIRD, KATHERINE",WISTAR INSTITUTE,PA,"$115,014"
Ovarian Cancer,2015,NLM,1K01LM012100-01,,Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression,"ENG, KEVIN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$168,195"
Ovarian Cancer,2015,NCI,5R01CA164122-04,,B7-H1 Signaling in Ovarian Cancer,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$310,213"
Ovarian Cancer,2015,NCI,5R01CA111882-09,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$272,318"
Ovarian Cancer,2015,NCI,5U01CA168409-04,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,420,487"
Ovarian Cancer,2015,NCI,5U01CA181628-02,,Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery,"PTASZEK, MARCIN",UNIVERSITY OF MARYLAND BALT CO CAMPUS,MD,"$196,403"
Ovarian Cancer,2015,NCI,5R01CA172404-03,,Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer,"RAMUS, SUSAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$687,307"
Ovarian Cancer,2015,NCI,1R21CA194626-01,,(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women,"ORSULIC, SANDRA",CEDARS-SINAI MEDICAL CENTER,CA,"$227,288"
Ovarian Cancer,2015,NCI,5R01CA176166-02,,Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer,"CANTOR, SHARON",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$347,563"
Ovarian Cancer,2015,NCI,5R21CA182748-02,,Targeting TF/CD44v6 for In Vivo Nano-generated  alpha-therapy of Ovarian Cancer,"DEUTSCHER, SUSAN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$198,177"
Ovarian Cancer,2015,NICHD,1R15HD075257-01A1,,Regulation of Primordial Follicle Formation and Oocyte Survival,"PEPLING, MELISSA",SYRACUSE UNIVERSITY,NY,"$440,204"
Ovarian Cancer,2015,NCI,5U01CA116167-08,,BRCA1 and BRCA2 missense mutations and breast cancer risk,"COUCH, FERGUS",MAYO CLINIC ROCHESTER,MN,"$527,128"
Ovarian Cancer,2015,NCI,5R21CA178468-02,,Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy,"NANJUNDAN, MEERA",UNIVERSITY OF SOUTH FLORIDA,FL,"$161,301"
Ovarian Cancer,2015,NCI,1R03CA184306-01A1,,Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$92,196"
Ovarian Cancer,2015,NCI,5F32CA183214-02,,The use of epigenetic therapy to activate an immune response in ovarian cancer,"CHIAPPINELLI, KATHERINE",JOHNS HOPKINS UNIVERSITY,MD,"$54,194"
Ovarian Cancer,2015,NCI,5R01CA124515-10,,Vascular Leukocytes Influence the Tumor Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$340,955"
Ovarian Cancer,2015,NCCAM,5R01AT005295-05,,Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$349,309"
Ovarian Cancer,2015,NCI,5R01CA166907-03,,Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity,"RAMKUMAR, VICKRAM",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$301,918"
Ovarian Cancer,2015,NCI,5U01CA168870-04,,Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer,"ABBOTT, KAREN",UNIV OF ARKANSAS FOR MED SCIS,AR,"$441,461"
Ovarian Cancer,2015,NCI,5R03CA189462-02,,Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer,"DINULESCU, DANIELA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$85,285"
Ovarian Cancer,2015,NCI,5R01CA181258-02,,Chemically Programmed Bispecific Antibodies for Cancer Therapy,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$398,400"
Ovarian Cancer,2015,NCI,2R01CA142698-06,,Molecular mechanism and relevance of microRNAs in DSB repair pathway choice,"CHOWDHURY, DIPANJAN",DANA-FARBER CANCER INST,MA,"$408,989"
Ovarian Cancer,2015,NCI,2R01CA115483-11,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$305,863"
Ovarian Cancer,2015,NCI,5P01CA066726-18,5805,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$302,808"
Ovarian Cancer,2015,NCI,5R01CA158318-05,,mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$347,118"
Ovarian Cancer,2015,NCI,5R21CA187765-02,,"Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer?","COOPER, PRISCILLA",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$214,718"
Ovarian Cancer,2015,NCI,1R01CA190176-01A1,,Effector T Cell Trafficking in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$514,525"
Ovarian Cancer,2015,NCI,5R21CA187278-02,,Diagnostic Assays for OVCA Recurrence using Paraneoplastic Antigens and Epitopes,"TAINSKY, MICHAEL",WAYNE STATE UNIVERSITY,MI,"$198,360"
Ovarian Cancer,2015,NCI,2R01CA138835-06A1,,The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$332,509"
Ovarian Cancer,2015,NCI,5R21CA187512-02,,TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$176,175"
Ovarian Cancer,2015,NCI,5R01CA121113-09,,Large-scale Genetic Analyses of Human Cancer,"VELCULESCU, VICTOR",JOHNS HOPKINS UNIVERSITY,MD,"$279,212"
Ovarian Cancer,2015,NCI,5K23CA159391-04,,Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus,"PEIKERT, TOBIAS",MAYO CLINIC ROCHESTER,MN,"$164,160"
Ovarian Cancer,2015,NCI,1R01CA178048-01A1,,Fas protects cancer stem cells from death,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$353,419"
Ovarian Cancer,2015,NCI,5K07CA166210-03,,Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer,"WRIGHT, ALEXI",DANA-FARBER CANCER INST,MA,"$177,120"
Ovarian Cancer,2015,NCI,5R01CA178687-03,,Effects of common polymorphisms in immune sensors in tumor immunosurveillance,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$377,972"
Ovarian Cancer,2015,NCI,1R01CA195670-01,,The Tumor Suppressor Role of SMARCA4 in SCCOHT,"WEISSMAN, BERNARD",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$697,118"
Ovarian Cancer,2015,NCI,1R01CA182413-01A1,,Origins of Ovarian Carcinoma,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY,NY,"$358,780"
Ovarian Cancer,2015,NCI,1R01CA188900-01A1,,Novel immunological biomarkers ovarian cancer prognosis,"SEGAL, BRAHM",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$589,735"
Ovarian Cancer,2015,NCI,5P30CA046592-27,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$310,178"
Ovarian Cancer,2015,NCI,5R21CA186846-02,,Integrated Microfluidic Exosome Profiling for Early Detection of Cancer,"ZENG, YONG",UNIVERSITY OF KANSAS LAWRENCE,KS,"$212,274"
Ovarian Cancer,2015,NIAID,5K06AI004739-54,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2015,NCI,5R01CA180710-03,,Targeting nucleotide excision repair in combination cancer therapy,"TURCHI, JOHN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Ovarian Cancer,2015,NCI,5R01CA178535-03,,The contribution of rare alleles to ovarian cancer in the population,"GAYTHER, SIMON",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$609,595"
Ovarian Cancer,2015,NCI,7R01CA187209-02,,Functional analysis of BRCA1 in DNA damage response and tumor suppression,"YU, XIAOCHUN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$352,750"
Ovarian Cancer,2015,NCI,5F31CA183463-02,,Regulation of REDD1 and caspase-2 by FASN inhibition in ovarian cancer,"LINDBLOM, KELLY",DUKE UNIVERSITY,NC,"$33,326"
Ovarian Cancer,2015,NCI,5F30CA189316-02,,The Role of NFAT3 in Quiescence and Chemoresistance in Ovarian Cancer Stem Cells,"IYENGAR, MANGALA",UNIVERSITY OF MICHIGAN,MI,"$33,625"
Ovarian Cancer,2015,NCI,1R01CA195723-01,,Validating a mouse model of ovarian cancer for early detection through imaging,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$572,656"
Ovarian Cancer,2015,NCI,5R41CA180773-02,,Ovarian cancer using novel nanoparticle formulations,"CHIRIVA-INTERNATI, MAURIZIO","KIROMIC, LLC",TX,"$101,844"
Ovarian Cancer,2015,NCI,5U24CA160036-05,,Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,859,557"
Ovarian Cancer,2015,NCI,1F32CA196008-01,,Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer,"CHEN, HSING-YU",HARVARD MEDICAL SCHOOL,MA,"$54,194"
Ovarian Cancer,2015,NCI,1F31CA186376-01A1,,Role of estrogen receptor-alpha in ovarian cancer,"ANDERSEN, COURTNEY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$43,120"
Ovarian Cancer,2015,NCI,5R01CA131582-06,,Identification of Ovarian Cancer Plasma Biomarkers,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$440,659"
Ovarian Cancer,2015,NCI,2R01CA095175-11A1,,Analysis of BRCA1 Recombination Functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$330,600"
Ovarian Cancer,2015,NCI,5F31CA174316-04,,Structural mutation analysis of PTEN and its possible genotype-phenotype correlat,"SMITH, IRIS",UNIVERSITY OF HOUSTON,TX,"$28,622"
Ovarian Cancer,2015,NCI,5R01CA164729-04,,"Integrative Cancer Genomics: Drivers, Pathways and Drugs","PE'ER, DANA",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$554,295"
Ovarian Cancer,2015,NCI,5K01CA172591-04,,"EGF receptor, DNA methylation and platinum resistance in ovarian cancer","SAMUDIO-RUIZ, SABRINA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$129,216"
Ovarian Cancer,2015,NCI,5U54CA096300-13,6961,In Vivo Assessment of Localized Magnetic Fluid Hyperthermia for Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF PUERTO RICO,PR,"$89,694"
Ovarian Cancer,2015,NCI,5R01CA184717-02,,The Regulation of Cisplatin resistance in ovarian cancer,"ZHU, WENGE",GEORGE WASHINGTON UNIVERSITY,DC,"$328,888"
Ovarian Cancer,2015,NCI,5U54CA163071-04,7991,Identifying Cancer Health Communication Channels for Hispanic Audiences,"JIMENEZ, JUILO",PONCE SCHOOL OF MEDICINE,PR,"$91,909"
Ovarian Cancer,2015,NCI,5R21CA181923-02,,"Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer","PIKE, MALCOLM",SLOAN-KETTERING INST CAN RESEARCH,NY,"$191,291"
Ovarian Cancer,2015,NCI,5F30CA183395-02,,Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy,"COCCE, KIMBERLY",DUKE UNIVERSITY,NC,"$33,531"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5590,"Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity","ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$476,157"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5591,Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov,"SHRIKANT, PROTUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$617,258"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5593,MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1,"KALINSKI, PAWEL",UNIVERSITY OF PITTSBURGH,PA,"$628,850"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5594,Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$94,889"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5595,Administrative Core,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$53,116"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5596,Biospecimen Core,"MORRISON, CARL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$52,762"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5597,Biostatistics/Medical Informatics,"HUTSON, ALAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$40,604"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5598,Immune Monitoring Core,"WALLACE, PAUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$72,022"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5599,Developmental Research Program,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$48,893"
Ovarian Cancer,2015,NCI,5P50CA159981-03,5600,Career Development Program,"LELE, SHASHIKANT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$43,449"
Ovarian Cancer,2015,NCI,5R01CA163451-04,,"Psychological stress, associate biologic mediators, and ovarian cancer risk","TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$412,105"
Ovarian Cancer,2015,NCI,5R21CA175975-02,,Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer,"PEIPER, STEPHEN",THOMAS JEFFERSON UNIVERSITY,PA,"$169,650"
Ovarian Cancer,2015,NCI,5P01CA154292-05,5435,Risk Assessment in Community Practice: Developing Better Models,"KERLIKOWSKE, KARLA",GROUP HEALTH COOPERATIVE,WA,"$477,743"
Ovarian Cancer,2015,NCI,5R42CA156933-03,,Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer,"KOPECEK, JINDRICH",THERATARGET,UT,"$492,378"
Ovarian Cancer,2015,NCI,5F30CA171715-04,,Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer,"LOU, DIANNE",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$37,308"
Ovarian Cancer,2015,NCI,5R01CA181808-02,,Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,"RICHARDS, JOANNE",BAYLOR COLLEGE OF MEDICINE,TX,"$336,565"
Ovarian Cancer,2015,NCI,5R03CA182120-02,,"Inflammation, autoimmunity and ovarian cancer","LUBORSKY, JUDITH",WOODS HOLE OCEANOGRAPHIC INSTITUTION,MA,"$69,119"
Ovarian Cancer,2015,NCI,5UM1CA182910-02,,Shanghai Womens Health Study,"ZHENG, WEI",VANDERBILT UNIVERSITY,TN,"$1,315,484"
Ovarian Cancer,2015,NCI,5U01CA184910-02,,Validation of findings from the Epigenome-Wide Association Study of Breast Cancer,"STURGEON, SUSAN",UNIVERSITY OF MASSACHUSETTS AMHERST,MA,$1
Ovarian Cancer,2015,NCI,5R01CA188025-02,,Iron addiction and the biology of ovarian cancer,"TORTI, SUZY",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$379,016"
Ovarian Cancer,2015,NCI,2P30CA047904-27,6388,Cancer Epidemiology and Prevention Program (Project-005),"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$36,087"
Ovarian Cancer,2015,NCI,2P30CA047904-27,6390,Breast and Ovarian Cancer Program (Project-007),"LEE, ADRIAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$34,779"
Ovarian Cancer,2015,OD,5R03CA178763-02,,Young Women From BRCA1/2 Families: A Family History And A Future,"O'NEILL, SUZANNE",GEORGETOWN UNIVERSITY,DC,"$77,750"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7019,Biospecimens and Patient Registry,"KEENEY, GARY",MAYO CLINIC ROCHESTER,MN,"$132,843"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7020,Core C - Biostatistics Core,"OBERG, ANN",MAYO CLINIC ROCHESTER,MN,"$146,934"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7021,Core D - Animal Models Core,"HALUSKA, PAUL",MAYO CLINIC ROCHESTER,MN,"$127,738"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7022,Administrative Core,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$587,017"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7023,Project 1 - PARP Project,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$173,132"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7024,Project 6 - PKC Iota,"FIELDS, ALAN",MAYO CLINIC ROCHESTER,MN,"$271,794"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7025,Project 7 - Metformin,"LENGYEL, ERNST",MAYO CLINIC ROCHESTER,MN,"$337,376"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7026,Project 8 - TH17 Dendritic Cell Vaccine,"KNUTSON, KEITH",MAYO CLINIC ROCHESTER,MN,"$265,812"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7027,Developmental Reserach Pilot Projects,"CLIBY, WILLIAM",MAYO CLINIC ROCHESTER,MN,"$94,902"
Ovarian Cancer,2015,NCI,2P50CA136393-06A1,7028,Career Development,"GOODE, ELLEN",MAYO CLINIC ROCHESTER,MN,"$47,451"
Ovarian Cancer,2015,NCI,5P30CA010815-46,6194,Tumor Microenvironment and Metastasis,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$31,164"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7470,Adminstrative Core,"SPRIGGS, DAVID",SLOAN-KETTERING INST CAN RESEARCH,NY,"$82,874"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7471,Biostatistics Core,"IASONOS, ALEXIA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$79,911"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7472,Pathology Core,"DELAIR, DEBORAH",SLOAN-KETTERING INST CAN RESEARCH,NY,"$82,873"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7473,MUC16 Antibody Based Strategies for Imaging and Therapy,"SPRIGGS, DAVID",SLOAN-KETTERING INST CAN RESEARCH,NY,"$580,100"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7474,Personalized Immunotherapy of Patients with Ovarian Cancer,"SABBATINI, PAUL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$497,223"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7475,Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells,"BRENTJENS, RENIER",SLOAN-KETTERING INST CAN RESEARCH,NY,"$414,354"
Ovarian Cancer,2015,NCI,1P01CA190174-01A1,7476,Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain,"RAVETCH, JEFFREY",SLOAN-KETTERING INST CAN RESEARCH,NY,"$315,472"
Ovarian Cancer,2015,NCI,5F31CA192891-02,,Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer,"PRICE, JESSICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$43,887"
Ovarian Cancer,2015,NCI,5U54CA118948-10,8553,Development Core,"MANNE, UPENDER",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$527,326"
Ovarian Cancer,2015,NCI,1R01CA197359-01,,Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy,"BERLIN, JACOB",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$388,875"
Ovarian Cancer,2015,NCI,1R21CA197225-01,,Generation and characterization of adduct-specific anti cisplatin DNA antibodies,"SCHARER, ORLANDO",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$204,071"
Ovarian Cancer,2015,NCI,1R01CA199004-01,,Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$511,177"
Ovarian Cancer,2015,NCI,1R35CA197458-01,,GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER,"KING, MARY-CLAIRE",UNIVERSITY OF WASHINGTON,WA,"$927,000"
Ovarian Cancer,2015,NCI,1R21CA187289-01A1,,Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer,"LIM, CAROL",UNIVERSITY OF UTAH,UT,"$162,038"
Ovarian Cancer,2015,NCI,1R15CA188847-01A1,,Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy,"XU, PEISHENG",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$366,250"
Ovarian Cancer,2015,NCI,1R03CA191447-01A1,,Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes,"WALDRON, LEVI",HUNTER COLLEGE,NY,"$77,583"
Ovarian Cancer,2015,NCI,1R21CA198409-01,,Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1,"HURLEY, THOMAS",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$203,397"
Ovarian Cancer,2015,NCI,1R21CA198795-01,,PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer,"AVRIL, NORBERT",CASE WESTERN RESERVE UNIVERSITY,OH,"$185,247"
Ovarian Cancer,2015,NCI,1R21CA191725-01A1,,4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INST,MA,"$223,181"
Ovarian Cancer,2015,NCI,1R03CA198822-01,,Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer,"SYED, VIQAR",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$77,878"
Ovarian Cancer,2015,NCI,1R43CA192674-01A1,,NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION,"LELENTAL, MARK",CATASSAYS,NY,"$225,000"
Ovarian Cancer,2015,NCI,1R01CA193136-01A1,,MDSCs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$498,257"
Ovarian Cancer,2015,RMAP,4UH3TR000943-03,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$999,500"
Ovarian Cancer,2015,NCI,2R01CA142746-06A1,,Enzyme-instructed self-assembly for molecular anticancer nanomedicines,"XU, BING",BRANDEIS UNIVERSITY,MA,"$383,751"
Ovarian Cancer,2015,NCI,1R01CA188571-01A1,,"DYRK1A signaling in control of cell growth, proliferation and DNA damage repair","LITOVCHICK, LARISA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$348,844"
Ovarian Cancer,2015,NCI,1R01CA188943-01A1,,Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors,"HILDEBRANDT, MICHELLE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$1,234,720"
Ovarian Cancer,2015,NCI,2R01CA135354-05,,ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$380,000"
Ovarian Cancer,2015,NCI,5F31CA186625-02,,Refining ovarian cancer subtype classifiers to incorporate biologic features,"RUDD, JAMES",DARTMOUTH COLLEGE,NH,"$43,120"
Ovarian Cancer,2015,NCI,3P50CA159981-03S1,,RPCI-UPCI Ovarian Cancer SPORE,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$66,758"
Ovarian Cancer,2015,NCI,3UM1CA173642-03S1,,Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI Clinical Trial and Observational Cohorts,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$113,842"
Ovarian Cancer,2015,NINR,1F31NR015170-01A1,,Hormone Therapy Decision Making in Older Women,"HUNTER, MARY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$34,571"
Ovarian Cancer,2015,NCI,1F30CA192648-01A1,,Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors,"MAHAPATRA, LILY",UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,IL,"$48,120"
Ovarian Cancer,2015,NCI,1R01CA193578-01A1,,Tunable Microchip Sorting of BRCA1 Nuclear Assemblies,"KELLY, DEBORAH",VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,"$353,386"
Ovarian Cancer,2015,NCI,2R01CA102310-12A1,,Role of FAK in Tumorigenesis,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$331,313"
Ovarian Cancer,2015,NCI,1R01CA196200-01A1,,Ovarian Cancer Chemoprevention,"BENBROOK, DORIS",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$611,847"
Ovarian Cancer,2015,NCI,3R01CA047135-25S1,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$38,168"
Ovarian Cancer,2015,NCI,1SC2CA206194-01A1,,Theranostic nanoparticles for dual modality cancer therapy,"CZAJKOWSKA, ANETA",BROOKLYN COLLEGE,NY,"$157,000"
Ovarian Cancer,2015,NIBIB,1R43EB021212-01,,CTC Screening Assay to Address Health Disparities in Women with Ovarian Cancer,"HUPERT, MATEUSZ","BIOFLUIDICA, INC",NC,"$199,848"
Ovarian Cancer,2015,NIGMS,1R01GM116829-01,,Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaks,"MER, GEORGES",MAYO CLINIC ROCHESTER,MN,"$314,025"
Ovarian Cancer,2015,NCI,261200800001E-77-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$2,282,355"
Ovarian Cancer,2015,NCI,261201100008C-13-0-1,,CENTRAL DATA COLLECTION CENTER (CDCC) CONTINUED FOLLOW-UP OF PLCO,"MATHEW, SUNITHA","WESTAT, INC.",MD,"$1,716,430"
Ovarian Cancer,2015,NCI,3R01CA047135-25S2,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$63,494"
Ovarian Cancer,2015,NCI,3R01CA142783-05S2,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$60,458"
Ovarian Cancer,2015,RMAP,3UH3TR000943-03S1,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$79,168"
Ovarian Cancer,2015,NICHD,3R01HD073499-03S1,,Genetic regulation of ovariole development in Drosophila,"EXTAVOUR, CASSANDRA",HARVARD UNIVERSITY,MA,"$100,001"
Ovarian Cancer,2015,NCI,7R01CA142081-06,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",UNIVERSITY OF VIRGINIA,VA,"$1,228,381"
Ovarian Cancer,2015,NCI,3U54CA096297-13S2,,UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297),"CRUZ-CORREA, MARCIA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$152,250"
Ovarian Cancer,2015,OD,3R01CA138835-06A1S1,,The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$40,000"
Ovarian Cancer,2015,NCI,3U54CA096297-13S1,,UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2),"CRUZ-CORREA, MARCIA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$110,195"
Ovarian Cancer,2015,NCI,4R00CA184043-03,,Targeting Ovarian Cancer via Cooperative Oncogene Interactions,"HARGREAVES, DIANA",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$249,000"
Ovarian Cancer,2015,NIBIB,7R21EB019147-02,,Quantitative Endoscopic Imaging and Structured Light Delivery for Controlled Drug,"SUNAR, ULAS",WRIGHT STATE UNIVERSITY,OH,"$225,227"
Ovarian Cancer,2015,NCI,4R00CA166228-03,,A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer,"GATZA, MICHAEL",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$249,000"
Ovarian Cancer,2015,NCI,4R00CA184415-02,,Functional Analysis of LncRNAs in Epithelial Ovarian Cancer,"LAWRENSON, KATE",CEDARS-SINAI MEDICAL CENTER,CA,"$249,000"
Ovarian Cancer,2015,NCI,3P50CA083639-15S1,,The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$901,656"
Ovarian Cancer,2015,NCI,3P50CA083636-15S1,,Pacific Ovarian Cancer Research Consortium,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$901,655"
Ovarian Cancer,2015,NCI,3U01CA084955-15S1,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$18,078"
Ovarian Cancer,2015,NCI,7R01CA132755-08,,Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis,"YU, XIAOCHUN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$31,739"
Ovarian Cancer,2015,NCI,3U01CA152637-05S1,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$93,620"
Ovarian Cancer,2015,NCI,3U01CA113916-10S1,,Fox Chase Clinical Epidemiology and Validation Center,"ENGSTROM, PAUL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$241,693"
Ovarian Cancer,2015,NCI,3U01CA152755-05S1,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$89,000"
Ovarian Cancer,2015,NCI,3U54CA096297-13S3,,UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2),"CRUZ-CORREA, MARCIA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$198,411"
Ovarian Cancer,2015,NCI,261201500011C-0-0-1,,IGF::OT::IGF TITLE: VITA-CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD.,"CHEN, PH.D., WEN-TIEN","VITATEX, INC.",NY,"$291,250"
Ovarian Cancer,2015,NCI,261201500046C-0-0-1,,IGF::OT::IGF DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS,"KEIRSTEAD, HANS","CALADRIUS BIOSCIENCES, INC.",NY,"$300,000"
Ovarian Cancer,2015,NHGRI,1ZIAHG000120-19,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$92,603"
Ovarian Cancer,2015,NHGRI,1ZIAHG200323-11,,"Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions","ELNITSKI, LAURA",NIH,,"$1,578,827"
Ovarian Cancer,2015,NCI,1ZIABC006161-32,,DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,"POMMIER, YVES",NIH,,"$843,796"
Ovarian Cancer,2015,NCI,1ZIABC009052-26,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$2,058,212"
Ovarian Cancer,2015,NCI,1ZIABC010627-12,,Clinical Pharmacogenetics,"FIGG, WILLIAM",NIH,,"$719,430"
Ovarian Cancer,2015,NCI,1ZIABC010657-11,,Intracellular In vivo Imaging,"CHOYKE, PETER",NIH,,"$1,016,705"
Ovarian Cancer,2015,NCI,1ZIABC010661-11,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$517,502"
Ovarian Cancer,2015,NCI,1ZIABC010830-09,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$1,215,165"
Ovarian Cancer,2015,NCI,1ZIABC010973-08,,Analyses of human T regulatory cells,"TSANG, KWONG YOK",NIH,,"$579,726"
Ovarian Cancer,2015,NCI,1ZIABC011054-08,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$912,704"
Ovarian Cancer,2015,NCI,1ZIABC011055-08,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$411,634"
Ovarian Cancer,2015,NCI,1ZIABC011188-07,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$532,298"
Ovarian Cancer,2015,NCI,1ZIABC011311-06,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$453,306"
Ovarian Cancer,2015,NCI,1ZIABC011315-06,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$60,847"
Ovarian Cancer,2015,NCI,1ZIABC011353-06,,"Validation of, and therapeutic evaluation in ovarian cancer GEM models","VAN DYKE, TERRY",NIH,,"$240,865"
Ovarian Cancer,2015,NCI,1ZIABC011525-03,,Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,"LEE, JUNG-MIN",NIH,,"$661,211"
Ovarian Cancer,2015,NCI,1ZIABC011584-02,,Clinical trials in womens cancers,"ANNUNZIATA, CHRISTINA",NIH,,"$243,388"
Ovarian Cancer,2015,NCI,1ZIACP010126-20,,Hormone-Related Cancers,"BRINTON, LOUISE",NIH,,"$5,979,659"
Ovarian Cancer,2015,NCI,1ZIACP010128-20,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"BRINTON, LOUISE",NIH,,"$298,121"
Ovarian Cancer,2015,NCI,1ZIACP010142-17,,Genetic Modifiers of Cancer Risk,"SAVAGE, SHARON",NIH,,"$417,815"
Ovarian Cancer,2015,NCI,1ZIACP010144-17,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"SAVAGE, SHARON",NIH,,"$7,232,793"
Ovarian Cancer,2015,NCI,1ZIACP010145-16,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"SAVAGE, SHARON",NIH,,"$459,731"
Ovarian Cancer,2015,NCI,1ZIACP010152-16,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$2,139,074"
Ovarian Cancer,2015,NCI,1ZIACP010182-13,,Epidemiologic Field Studies,"GAIL, MITCHELL",NIH,,"$572,342"
Ovarian Cancer,2015,NCI,1ZIACP010187-11,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$118,607"
Ovarian Cancer,2015,NCI,1ZIACP010188-11,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$769,379"
Ovarian Cancer,2015,NCI,1ZIACP010200-08,,GEI - Genome-Wide Association Studies,"CAPORASO, NEIL",NIH,,"$174,823"
Ovarian Cancer,2015,NCI,1ZIACP010207-06,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$664,206"
Ovarian Cancer,2015,NCI,1ZIASC006353-33,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$1,001,634"
Ovarian Cancer,2015,NIAID,1ZIAAI001038-08,,Mechanisms of Antitumor Action of Human Interferon,"ZOON, KATHRYN",NIH,,"$336,445"
Ovarian Cancer,2015,NCI,261201500041I-0-26100002-1,,IGF::OT::IGF 2015-E03B/OVARIAN CANCER CHEMOPREVENTION (SHETA2) PERIOD OF PERFORMANCE 09/24/2015 - 09/23/2017,"BAUGHMAN, KATHRYN",SRI INTERNATIONAL,CA,"$509,357"
Ovarian Cancer,2015,NCI,261201500038I-0-26100002-1,,IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH),"ASCH, LISA",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$628,343"
